Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 12/20 | 0.78 |
| ▸ | DRD2 | P14416 | 2/20 | 0.61 |
| ▸ | HTR1A | P08908 | 1/20 | 0.61 |
| ▸ | HTR7 | P34969 | 1/20 | 0.61 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.38 |
| ▸ | DRD3 | P35462 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21290263 | 1.00 | TAAR1 (0.78) | TAAR1DRD2HTR1AHTR7KEAP1 | |
| SCHEMBL14903754 | 0.88 | TAAR1 (1.00) | TAAR1DRD2HTR1AHTR7KEAP1 | |
| SCHEMBL15679325 | 0.85 | TAAR1 (0.78) | TAAR1DRD2HTR1AHTR7KEAP1 | |
| SCHEMBL28945890 | 0.83 | TAAR1 (0.74) | TAAR1DRD2HTR1AHTR7KEAP1 | |
| SCHEMBL28945878 | 0.81 | TAAR1 (0.71) | TAAR1DRD2HTR1AHTR7KEAP1 | |
| SCHEMBL21282227 | 0.80 | TAAR1 (0.71) | TAAR1DRD2HTR1AHTR7KEAP1 | |
| SCHEMBL30487344 | 0.79 | TAAR1 (0.67) | TAAR1DRD2HTR1AHTR7KEAP1 | |
| SCHEMBL28945894 | 0.78 | TAAR1 (0.66) | TAAR1DRD2HTR1AHTR7KEAP1 | |
| SCHEMBL29140409 | 0.78 | TAAR1 (0.66) | TAAR1DRD2HTR1AHTR7KEAP1 | |
| SCHEMBL14903739 | 0.76 | TAAR1 (1.00) | TAAR1DRD2HTR1AHTR7KEAP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019161236-A1 | METHODS OF TREATING SOCIAL FUNCTION DISORDERS | SUNOVION PHARMACEUTICALS INC. (US) | 2019-08-22 | — | — | WO | disclosed |